Its a quarterly results conference call and I think the emphasis on questions should be on earnings. Its only through the market getting a proper understanding of future revenue will the price break the 11.5c price ceiling.
How is the revenue broken down?
How is the revenue growing month by month for the various parties?
You have spoken before about several other telehealth companies being interested in ResAppDx. Why is it taking so long for them to sign up?
The $3 mil Pfizer revenue is significant. Are there other parties showing similar interest?
Is Sleepcheck a dog?
RAP Price at posting:
11.3¢ Sentiment: Hold Disclosure: Held
